Innovative Student-Designed Device Aims to Improve Cardiac Imaging Procedures

A team of Rice University students has developed a novel device to stabilize intracardiac echocardiography catheters, improving efficiency and precision in cardiac ablation procedures. This innovative solution reduces the need for additional personnel during delicate heart surgeries.
Irregular heart rhythms impact over 4 million Americans, often requiring cardiac ablation treatments. This invasive procedure involves inserting flexible catheters through blood vessels to target specific areas of the heart, with real-time ultrasound imaging from inside the heart being crucial for guiding the process. However, a significant challenge during these procedures is maintaining the position of the imaging catheter. Typically, a second medical professional is needed solely to hold the catheter steady, which can be inefficient and resource-intensive.
Addressing this issue, a team of six senior engineering students from Rice University—known as AnchorCat—developed a device that stabilizes the intracardiac echocardiography catheter, enabling the primary surgeon to have precise control without requiring an extra hand. Their project was initiated by a challenge from the Texas Heart Institute, guided by clinical mentors Dr. Mehdi Razavi and Dr. Feng Gao, who provided ongoing feedback and helped ensure the device met clinical needs.
The students designed a system featuring a stable, weighted base for overall stability, a rotator with a ratcheting mechanism for accurate torque control, and a fixator ensuring the catheter handle remains securely in place while allowing access to its controls. Throughout development, the team refined their prototype, transitioning from a bulky articulating arm to a sleek, compact device. Their final model was a high-fidelity 3D-printed prototype made from polylactic acid plastic, integrated with commercial springs and bearings previously tested in animal models.
The team has filed a provisional patent, formed an LLC, and is currently in talks with medical device companies to license the design. The project left a lasting impression on team members, inspiring future careers in medicine, engineering, and biomedical innovation. Several team members plan to pursue further studies or careers in medical research, while the project also reinforced their sense of community and collaboration at Rice University.
Recognized for their innovation and potential impact, Team AnchorCat secured third place at the 2025 Huff OEDK Engineering Design Showcase and was a finalist at the National Design of Medical Devices Conference. Their work exemplifies the promising intersection of engineering and healthcare, driven by student ingenuity and mentorship.
Source: https://medicalxpress.com/news/2025-06-heart-student-device-imaging-cardiac.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Method Tracks Tumor Evolution to Combat Resistant High-Grade Serous Ovarian Cancer
Memorial Sloan Kettering researchers introduce CloneSeq-SV, a cutting-edge method to monitor tumor evolution and resistance in high-grade serous ovarian cancer, opening new avenues for personalized treatment strategies.
Understanding Dormant Cancer Cells: How Chemotherapy Can Trigger Awakening and How Senolytic Drugs Might Prevent Relapse
New research reveals how chemotherapy can awaken dormant cancer cells, leading to relapse, and how senolytic drugs may offer a promising approach to prevent this by targeting the cellular environment that facilitates tumor reactivation.
President Trump Announces Plan to Sign Executive Order Aiming to Reduce US Drug Prices
President Trump announced plans to sign an executive order implementing a 'Most Favored Nation' policy, aiming to significantly reduce prescription drug prices in the US by linking them to the lowest prices paid internationally.
Gene Fusions and Their Role in Kidney Cancer Development Through Condensate Formation
Research uncovers how gene fusions in kidney cancer promote tumor growth through the formation of biomolecular condensates that hijack gene transcription processes, offering new therapeutic targets.



